Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03181230 · ClinicalTrials.gov registry record

Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome

A clinical trial, sponsored by University of Colorado, Denver.

Completed
Registry status
21
Enrollment target

NCT03181230: Completed study, sponsored by University of Colorado, Denver.

NCT03181230 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03181230 has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
21 participants
Enrollment target

Study Summary

This study plans to learn more about how the energy system works in girls with Turner syndrome. This is important to know so that the investigators understand how Turner syndrome relates to diseases such as diabetes, extra weight gain, heart disease and liver disease, and how this impacts day to day life.

Primary Outcome

Peak oxygen consumption (VO2 peak) with a standard graded exercise (bicycle) test

Interventions

  • OTHER No intervention

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2017-05-26
Est. Completion 2018-12-31
University of Colorado, Denver

1,283 total trials

What the finished NCT03181230 record still lists

NCT03181230 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.

NCT03181230 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03181230 about?

NCT03181230 is a clinical study titled "Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome". This study plans to learn more about how the energy system works in girls with Turner syndrome. This is important to know so that the investigators understand how Turner syndrome relates to diseases such as diabetes, extra weight gain, heart disease and liver disease, and how this impacts day to day...

What is the current status of trial NCT03181230?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2017-05-26. Estimated completion is 2018-12-31.

What interventions are being tested in trial NCT03181230?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT03181230?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03181230, the US trial registry maintained by the National Library of Medicine. NCT03181230 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.